Page last updated: 2024-08-21

oxymetholone and Anemia, Refractory, with Excess of Blasts

oxymetholone has been researched along with Anemia, Refractory, with Excess of Blasts in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hurtado, R; Labardini-Méndez, J; Majluf-Cruz, A; Vargas-Vorackova, F	1

Trials

1 trial(s) available for oxymetholone and Anemia, Refractory, with Excess of Blasts

Article	Year
Refractory anemia with excess of blasts: increased survival when treated with cyclophosphamide, methotrexate and 6-mercaptopurine. European journal of haematology, 1999, Volume: 62, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anabolic Agents; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Oxymetholone; Platelet Count; Survival Analysis; Time Factors	1999

Article

Year

Refractory anemia with excess of blasts: increased survival when treated with cyclophosphamide, methotrexate and 6-mercaptopurine.

European journal of haematology, 1999, Volume: 62, Issue:4

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anabolic Agents; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Oxymetholone; Platelet Count; Survival Analysis; Time Factors

1999